Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Acanthosis Nigricansin PCOS Patients and Its Relation with Type 2 Diabetes Mellitus and Body Mass at a Tertiary Care Hospital in Southern India.

G S, A B, Kamath A, Shivaprakash P, Adhikari P, Up R, Hn G, Padubidri JR.

J Clin Diagn Res. 2013 Feb;7(2):317-9. doi: 10.7860/JCDR/2013/4930.2756. Epub 2013 Feb 1.

2.

Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.

Shi Y, Guo M, Yan J, Sun W, Zhang X, Geng L, Xu L, Chen Z.

Neuro Endocrinol Lett. 2007 Dec;28(6):807-10.

PMID:
18063948
3.

Prevalence of polycystic ovary syndrome in women with type 2 diabetes in Kerman, Iran.

Mirzaei F, Kazemi N.

Metab Syndr Relat Disord. 2008 Sep;6(3):215-7. doi: 10.1089/met.2008.0015.

PMID:
18710333
4.

Polycystic ovary syndrome: Is obesity a sine qua non? A clinical, hormonal, and metabolic assessment in relation to body mass index.

Saxena P, Prakash A, Nigam A, Mishra A.

Indian J Endocrinol Metab. 2012 Nov;16(6):996-9. doi: 10.4103/2230-8210.103011.

5.

Assessment of impaired glucose tolerance prevalence with hemoglobin A₁c and oral glucose tolerance test in 252 Turkish women with polycystic ovary syndrome: a prospective, controlled study.

Celik C, Abali R, Bastu E, Tasdemir N, Tasdemir UG, Gul A.

Hum Reprod. 2013 Apr;28(4):1062-8. doi: 10.1093/humrep/det002. Epub 2013 Jan 18.

6.

Acanthosis nigricans: clinical predictor of abnormal glucose tolerance in Asian women with polycystic ovary syndrome.

Charnvises K, Weerakiet S, Tingthanatikul Y, Wansumrith S, Chanprasertyothin S, Rojanasakul A.

Gynecol Endocrinol. 2005 Sep;21(3):161-4.

PMID:
16335908
7.

Prevalence of polycystic ovarian changes and polycystic ovary syndrome in premenopausal women with treated type 2 diabetes mellitus.

Kelestimur F, Unluhizarci K, Baybuga H, Atmaca H, Bayram F, Sahin Y.

Fertil Steril. 2006 Aug;86(2):405-10. Epub 2006 Jun 8.

PMID:
16762349
8.

Association of acanthosis nigricans with insulin resistance in patients with polycystic ovary syndrome.

Panidis D, Skiadopoulos S, Rousso D, Ioannides D, Panidou E.

Br J Dermatol. 1995 Jun;132(6):936-41.

PMID:
7662572
9.
11.

Assessment of glucose metabolism in polycystic ovary syndrome: HbA1c or fasting glucose compared with the oral glucose tolerance test as a screening method.

Lerchbaum E, Schwetz V, Giuliani A, Obermayer-Pietsch B.

Hum Reprod. 2013 Sep;28(9):2537-44. doi: 10.1093/humrep/det255. Epub 2013 Jun 11.

12.

Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome.

Kulshreshtha B, Ganie MA, Praveen EP, Gupta N, Lal Khurana M, Seith A, Dwivedi SN, Kumar G, Ammini AC.

Gynecol Endocrinol. 2008 Nov;24(11):637-43. doi: 10.1080/09513590802342858.

PMID:
19031221
13.

The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment.

Pasquali R, Gambineri A, Anconetani B, Vicennati V, Colitta D, Caramelli E, Casimirri F, Morselli-Labate AM.

Clin Endocrinol (Oxf). 1999 Apr;50(4):517-27.

PMID:
10468913
14.
15.

Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?

Wijeyaratne CN, Balen AH, Barth JH, Belchetz PE.

Clin Endocrinol (Oxf). 2002 Sep;57(3):343-50.

PMID:
12201826
16.

Prevalence of polycystic ovary syndrome in reproductive-aged women with type 2 diabetes.

Amini M, Horri N, Farmani M, Haghighi S, Sattari G, Pornaghshband Z, Aminorroaya A.

Gynecol Endocrinol. 2008 Aug;24(8):423-7. doi: 10.1080/09513590802306143.

PMID:
18850378
17.
18.

Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.

da Silva RC, Miranda WL, Chacra AR, Dib SA.

J Diabetes Complications. 2007 Mar-Apr;21(2):84-92.

PMID:
17331856
19.

Acanthosis nigricans and diabetes risk factors: prevalence in young persons seen in southwestern US primary care practices.

Kong AS, Williams RL, Smith M, Sussman AL, Skipper B, Hsi AC, Rhyne RL; RIOS Net Clinicians.

Ann Fam Med. 2007 May-Jun;5(3):202-8.

20.

The polycystic ovary syndrome per se is not associated with increased chronic inflammation.

Möhlig M, Spranger J, Osterhoff M, Ristow M, Pfeiffer AF, Schill T, Schlösser HW, Brabant G, Schöfl C.

Eur J Endocrinol. 2004 Apr;150(4):525-32.

Items per page

Supplemental Content

Write to the Help Desk